BN82002
BN82002 is a potent, selective and irreversible inhibitor of CDC25 phosphatase family. BN82002 inhibits CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A, and 25C-cat with IC50 values of 2.4, 3.9, 6.3, 5.4, and 4.6 μM, respectively. BN82002 displays ~20-fold greater selectivity over CD45 tyrosine phosphatase[1].
Product Specifications
CAS Number
[396073-89-5]
UNSPSC
12352005
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BN82002.html
Purity
60.00
Solubility
DMSO : ≥ 150 mg/mL
Smiles
OC1=C(CN(C)CCC2=CC=C([N+]([O-])=O)C=C2)C=C(N(C)C)C=C1OC
Molecular Formula
C19H25N3O4
Molecular Weight
359.42
References & Citations
[1]Brezak MC, et al. A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res. 2004 May 1;64 (9) :3320-5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human Mucosal addressin cell adhesion molecule 1 (MADCAM1), partial
Recombinant Human Mucosal addressin cell adhesion molecule 1 (MADCAM1), partial
Recombinant Human Mucosal addressin cell adhesion molecule 1 (MADCAM1), partial